For de læsioner, som har vist tilbagegang i højde og/ eller størrelse senest uge 12, kan applikationerne fortsættes forudsat at der stadig sker forbedring eller i det mindste vedligeholdelse af reaktionen, og at produktet fortsat tåles.
For those lesions that have shown a decrease in height and/ or area by week 12, applications may be continued providing that there is continued improvement or at least maintenance of the response and that the product continues to be tolerated.